[go: up one dir, main page]

FR2867682B1 - Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise. - Google Patents

Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.

Info

Publication number
FR2867682B1
FR2867682B1 FR0402911A FR0402911A FR2867682B1 FR 2867682 B1 FR2867682 B1 FR 2867682B1 FR 0402911 A FR0402911 A FR 0402911A FR 0402911 A FR0402911 A FR 0402911A FR 2867682 B1 FR2867682 B1 FR 2867682B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
active ingredient
anhydrous pharmaceutical
silicone agent
solubilized active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0402911A
Other languages
English (en)
Other versions
FR2867682A1 (fr
Inventor
Claire Mallard
Eve Ferrara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0402911A priority Critical patent/FR2867682B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to JP2007504452A priority patent/JP2007530515A/ja
Priority to AU2005225186A priority patent/AU2005225186A1/en
Priority to BRPI0509053-9A priority patent/BRPI0509053A/pt
Priority to MXPA06010767A priority patent/MXPA06010767A/es
Priority to CA002558884A priority patent/CA2558884A1/fr
Priority to PCT/FR2005/050171 priority patent/WO2005092347A2/fr
Priority to EP05739476A priority patent/EP1753436A2/fr
Priority to KR1020067019410A priority patent/KR20070032629A/ko
Priority to RU2006137291/15A priority patent/RU2006137291A/ru
Priority to US10/591,864 priority patent/US20070135379A1/en
Priority to CNA2005800093344A priority patent/CN1938033A/zh
Publication of FR2867682A1 publication Critical patent/FR2867682A1/fr
Application granted granted Critical
Publication of FR2867682B1 publication Critical patent/FR2867682B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0402911A 2004-03-22 2004-03-22 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise. Expired - Fee Related FR2867682B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR0402911A FR2867682B1 (fr) 2004-03-22 2004-03-22 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
KR1020067019410A KR20070032629A (ko) 2004-03-22 2005-03-18 실리콘 물질 및 용해된 활성 성분을 포함하는 무수약제학적 조성물
BRPI0509053-9A BRPI0509053A (pt) 2004-03-22 2005-03-18 composição farmacêutica anidra e uso de um agente siliconado e de uma composição
MXPA06010767A MXPA06010767A (es) 2004-03-22 2005-03-18 Composicion farmaceutica anhidra que asocia un agente siliconado y principio activo solubilizado.
CA002558884A CA2558884A1 (fr) 2004-03-22 2005-03-18 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise
PCT/FR2005/050171 WO2005092347A2 (fr) 2004-03-22 2005-03-18 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise
JP2007504452A JP2007530515A (ja) 2004-03-22 2005-03-18 シリコネート化された剤及び溶解された活性成分を組み合わせた無水の薬剤組成物
AU2005225186A AU2005225186A1 (en) 2004-03-22 2005-03-18 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
RU2006137291/15A RU2006137291A (ru) 2004-03-22 2005-03-18 Безводная фармацевтическая композиция, включающая силиконовый агент и растворимый активный компонент
US10/591,864 US20070135379A1 (en) 2004-03-22 2005-03-18 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
CNA2005800093344A CN1938033A (zh) 2004-03-22 2005-03-18 联用硅酸化试剂和溶液化活性成分的无水药物组合物
EP05739476A EP1753436A2 (fr) 2004-03-22 2005-03-18 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0402911A FR2867682B1 (fr) 2004-03-22 2004-03-22 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.

Publications (2)

Publication Number Publication Date
FR2867682A1 FR2867682A1 (fr) 2005-09-23
FR2867682B1 true FR2867682B1 (fr) 2009-06-05

Family

ID=34896683

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0402911A Expired - Fee Related FR2867682B1 (fr) 2004-03-22 2004-03-22 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.

Country Status (12)

Country Link
US (1) US20070135379A1 (fr)
EP (1) EP1753436A2 (fr)
JP (1) JP2007530515A (fr)
KR (1) KR20070032629A (fr)
CN (1) CN1938033A (fr)
AU (1) AU2005225186A1 (fr)
BR (1) BRPI0509053A (fr)
CA (1) CA2558884A1 (fr)
FR (1) FR2867682B1 (fr)
MX (1) MXPA06010767A (fr)
RU (1) RU2006137291A (fr)
WO (1) WO2005092347A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909284B1 (fr) 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
US20080145443A1 (en) 2006-12-15 2008-06-19 Kimberly-Clark Worldwide, Inc. Diaper rash composition and method
WO2008097850A1 (fr) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Compositions de tétracycline pour une administration topique
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
NZ578902A (en) * 2007-02-09 2012-01-12 Mcneil Ppc Inc Lotion composition for personal use
US8425923B2 (en) * 2007-02-09 2013-04-23 Dow Corning Corporation and McNeil-PPC, Inc. Lotion composition for personal use
GB0919650D0 (en) * 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
EP2709665A4 (fr) * 2011-05-02 2014-11-12 Lipidor Ab Traitement du psoriasis
US20140086857A1 (en) * 2011-05-13 2014-03-27 Quadsil, Inc. Compositions Comprising Siloxane Polymer
ES2401806B1 (es) * 2011-10-11 2014-06-10 Servicio Andaluz De Salud Uso de una composición que comprende un poli-organosiloxano.
US20140357729A1 (en) 2011-12-21 2014-12-04 Maruho Co., Ltd. Topical composition containing silicone base
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
EP2641585A1 (fr) * 2012-03-19 2013-09-25 Coty Germany GmbH Composition cosmétique de la peau avec effet apaisant et son utilisation
CN104271160B (zh) * 2012-04-27 2017-08-08 道康宁公司 包含基于有机硅的赋形剂以将活性物质递送到基底的局部用制剂组合物
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
GB201503590D0 (en) * 2015-03-03 2015-04-15 Davis Adrian Topical formulation
AU2018221889A1 (en) * 2017-02-15 2019-09-05 Botanix Pharmaceuticals Ltd Compositions for treating acne
WO2020247127A1 (fr) * 2019-06-07 2020-12-10 Paxmedica, Inc. Compositions et méthodes pour traiter des troubles du système nerveux central

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4574082A (en) * 1983-07-29 1986-03-04 Revlon, Inc. One-phase silicone-based cosmetic products containing wax
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
JPS62143970A (ja) * 1985-12-17 1987-06-27 Shin Etsu Chem Co Ltd ゲル状組成物
JPS62243621A (ja) * 1986-04-17 1987-10-24 Toray Silicone Co Ltd シリコ−ンゴム粒状物の製造方法
FI872553L (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Medium foer laekemedel foer lokalt bruk.
JPH0753646B2 (ja) * 1989-01-31 1995-06-07 東レ・ダウコーニング・シリコーン株式会社 化粧料
GB9109733D0 (en) * 1991-05-07 1991-06-26 Unilever Plc Cosmetic composition
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
US5654362A (en) * 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5929164A (en) * 1997-11-05 1999-07-27 Dow Corning Corporation Quenching post cure
EP0966972B1 (fr) * 1998-06-18 2003-09-24 Dow Corning France S.A. Composition topique contenant de la gomme de silicone
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
JP2001002555A (ja) * 1999-06-24 2001-01-09 Shin Etsu Chem Co Ltd 皮膚化粧料
US6103250A (en) * 1999-07-06 2000-08-15 Revlon Consumer Products Corporation Anhydrous cosmetic compositions containing emulsifying siloxane elastomer
JP4215918B2 (ja) * 1999-12-28 2009-01-28 日本メナード化粧品株式会社 化粧料
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
ATE410184T1 (de) * 2003-02-05 2008-10-15 Galderma Res & Dev Umkehremulsion mit mindestens einem gegenüber wasser empfindlichen wirkstoff und ihre anwendungen in kosmetik und dermatologie
FR2850575B1 (fr) * 2003-02-05 2007-04-13 Galderma Res & Dev Composition de type emulsion inverse contenant au moins un actif sensible a la presence d'eau, et ses utilisations en dermatologie
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
PT1686972E (pt) * 2003-11-21 2008-04-23 Galderma Res & Dev Composição pulverizável para a administração de derivados da itamina d
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
BRPI0511398A (pt) * 2004-06-17 2007-12-04 Galderma Sa composição farmacêutica anidra para o tratamento da psorìase e uso de um agente siliconado

Also Published As

Publication number Publication date
MXPA06010767A (es) 2007-07-04
KR20070032629A (ko) 2007-03-22
CN1938033A (zh) 2007-03-28
AU2005225186A1 (en) 2005-10-06
US20070135379A1 (en) 2007-06-14
FR2867682A1 (fr) 2005-09-23
BRPI0509053A (pt) 2007-08-21
CA2558884A1 (fr) 2005-10-06
JP2007530515A (ja) 2007-11-01
RU2006137291A (ru) 2008-04-27
WO2005092347A3 (fr) 2006-05-18
WO2005092347A2 (fr) 2005-10-06
EP1753436A2 (fr) 2007-02-21

Similar Documents

Publication Publication Date Title
FR2867682B1 (fr) Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
NO20034268D0 (no) Intravaginale legemiddelavleveringsinnretninger for administrering av et antimikrobielt middel
EP1824442A4 (fr) Compositions pharmaceutiques et therapeutiques derivees de garcinia mangostana l.
EP1513825A4 (fr) Medicament anti-tuberculeux: compositions et methodes
EP1477403A4 (fr) Distributeur de medicament
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
DK1545662T3 (da) Lægemiddelindgivelsessystem
EP1780202A4 (fr) Derive de quinoline et insecticide contenant cellui-ci comme constituant actif
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
NO20053143D0 (no) Farmasoytiske sammensetninger omfattende en basisk, henholdsvis sur legemiddelforbindelse, en sufaktant og en fysiologisk akseptabel vannloselig syre henholdsvis base.
NO20053224D0 (no) Patient controlled drug administration device.
FR2871695B1 (fr) Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
NO20053076D0 (no) Farmasoytisk formulering med en uloselig aktiv forbindelse.
EP2277566A3 (fr) Dispositifs médicaux contenant des analogues de rapamycine
EP2078731A4 (fr) Composition pharmaceutique comprenant un anticorps anti-hb-egf comme ingrédient actif
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
FR2889811B1 (fr) Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
EP1608395A4 (fr) Agent anticancereux comprenant une proteine lk8 en tant que principe actif
EP1961764A4 (fr) Produit d'addition de chaine de sucres et de peptide et produit pharmaceutique comprenant ce produit en tant que principe actif
EP1819323A4 (fr) Composition pharmaceutique renfermant un agent d'anti-nucleation
EP1729817A4 (fr) Systeme de delivrance de gene contenant le gene de la relaxine et composition pharmaceutique utilisant la relaxine

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20131129